Alberto De Caterina Selected Research

aluminoborate cement

4/2018

Development and validation of a risk stratification score for new-onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto De Caterina Research Topics

Disease

3	Myocardial Infarction 01/2019 - 01/2013
3	ST Elevation Myocardial Infarction 01/2019 - 01/2013
1	Infarction (Infarctions) 01/2019
1	Euthyroid Sick Syndromes (Euthyroid Sick Syndrome) 01/2019
1	Atrial Fibrillation 04/2018
1	Obesity 04/2018
1	Heart Failure 04/2016
1	Thrombosis (Thrombus) 04/2016
1	Acute Coronary Syndrome 01/2013
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2007
1	Heart Diseases (Heart Disease) 04/2005
1	Inflammation (Inflammations) 04/2005

Drug/Important Bio-Agent (IBA)

1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2019
1	aluminoborate cementIBA 04/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2018
1	AntigensIBA 01/2013
1	Clopidogrel (Plavix)FDA Link 01/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2013
1	von Willebrand FactorIBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 12/2007
1	CholesterolIBA 04/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2005
1	CytokinesIBA 04/2005

Therapy/Procedure

2	Therapeutics 01/2019 - 04/2005
1	Percutaneous Coronary Intervention 04/2018
1	Stents 04/2016